Search results
Results from the WOW.Com Content Network
A scientific review published in JAMA Psychiatry in 2016 found that people who use marijuana are more likely to develop temporary psychosis, as well as long-lasting mental disorders like ...
Forty-four percent used drugs, such as marijuana, as sleep aides. The same percentage cited drug use as a way to "stop worrying about a problem or forget bad memories." And 40% said they used to ...
A 2017 review suggests that cannabis has been shown to improve the mood of depression-diagnosed patients. [12] This is indicative of a longitudinal relationship between cannabis reduction and improvements in anxiety and depression. Anxiety and depression have been found to increase susceptibility to marijuana use. [52]
Some of the negative effects of 5F-AKB-48 reported by users included palpitations, paranoia, intense anxiety, and a taste like burned plastic. [12] In addition, while there are no fatal overdose cases linked to marijuana , [ 62 ] there are deaths linked to synthetic cannabinoids each year.
D’Souza added that cannabis use can have serious impacts on the developing brain because of its effects on the endocannabinoid system, a complex signaling system in the brain that marijuana targets.
Legal cannabis (marijuana) product. Overconsumption and reliance could lead to cannabis-induced amotivational syndrome. The term amotivational syndrome was first devised to understand and explain the diminished drive and desire to work or compete among the population of youth who are frequent consumers of cannabis and has since been researched through various methodological studies with this ...
Common SSRI side effects include nausea, agitation, anxiety, dizziness and more. These are temporary and mild in most cases, but may persist or become severe for some people. Drug interactions.
The CB 1 receptor antagonist rimonabant has shown efficacy in reducing the effects of cannabis in users, but with a risk for serious psychiatric side effects. [ 58 ] Naltrexone , a μ-opioid receptor antagonist, has shown mixed results for cannabis use disorder—both increasing the subjective effects of cannabis when given acutely, but ...